PMV Pharmaceuticals, Inc.
PMVP
$1.56
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -20.80% | -3.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.56% | -1.56% | |||
| Operating Income | 14.56% | 1.56% | |||
| Income Before Tax | 14.50% | 0.66% | |||
| Income Tax Expenses | 533.33% | -220.00% | |||
| Earnings from Continuing Operations | 14.35% | 0.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.35% | 0.71% | |||
| EBIT | 14.56% | 1.56% | |||
| EBITDA | 14.59% | 1.56% | |||
| EPS Basic | 14.70% | 2.55% | |||
| Normalized Basic EPS | 14.81% | 2.51% | |||
| EPS Diluted | 14.70% | 2.55% | |||
| Normalized Diluted EPS | 14.81% | 2.51% | |||
| Average Basic Shares Outstanding | 0.39% | 1.89% | |||
| Average Diluted Shares Outstanding | 0.39% | 1.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||